Sociedad Americana de Hirudoterapia

Agence Nationale des Produits Pharmaceutiques — Algérie

ANPP · Algeria · africa

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Algeria's National Agency for Pharmaceutical Products — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
africa
Country
Algeria
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Algerian Loi sanitaire (Law 18-11) — pharmaceutical and device provisions
  • Algerian national medical device regulatory framework

Prescriber Requirements

  • Conseil National de Déontologie Médicale–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

ANPP registration as applicable; Arabic and French-language labelling. Standard cold-chain conditions.

Import/Export Rules

ANPP and Ministry of Health import authorisation; veterinary services clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Algeria established ANPP in 2019 as a consolidated regulator; uptake of live-organism device classifications has not been independently mapped by ASH.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.